IPIRA Startups

IPIRA Startups

MuscleMatrix

Brief Description

MuscleMatrix is developing a hydrogel that could change how medics treat traumatic injuries on the battlefield, as well as revolutionize surgical repairs for civilians with soft tissue injuries. Traumatic and surgical injuries of soft tissue that involve underlying skeletal muscle remain one of the greatest challenges to tissue reconstruction. Severe injuries, such as those involving the loss of a substantial portion of muscle tissue, are not capable of healing on their own and are referred to as volumetric muscle loss (VML) injuries. By definition, VML results in...

Adapta Imaging, Inc.

Brief Description

Adapta Imaging, Inc. is developing a new type of radiofrequency (RF) coil, an essential component of Magnetic Resonance Imaging (MRI) hardware, which can operate at any frequency. The Any-nucleus Distributed Active Programmable Transmit (ADAPT) coil was invented at UC Berkeley in the lab of Dr. Chunlei Liu, a professor in the Department of Electrical Engineering and Computer Sciences, and the Helen Wills Neuroscience Institute. The ADAPT coil converts direct current power into RF magnetic fields with frequencies chosen by digital control signals, eliminating the need for...

Vivere Oncotherapies

Brief Description

Gene and cell therapies for cancer.

Timeline 2024. Company founded. Inventors

Adam Schieferecke, John Dueber, David Schaffer, Juan Eduardo Hurtado, Hyun-Cheol Lee

Algen Biotechnologies

Brief Description

Algen Biotechnologies is building a next-generation, functional genomics-based platform for the discovery of novel therapeutics for cancers with high unmet need. Algen’s research group focuses on developing and applying novel functional genomics technologies to address scientific challenges in drug discovery. The company's biologists and data scientists are collaborating to deliver innovative, patient-centric medicines for the toughest-to-treat diseases.

The company was founded to commercialize technology developed at UC Berkeley while Algen Biotechnologies CEO...

Tessera Therapeutics, Inc.

Brief Description

Developer of gene writing technology designed to permanently make small and large alterations to the human genome. The company's technology helps scientists and clinicians with the ability to write small and large therapeutic messages into the genome to treat diseases at their source, enabling healthcare providers to cure their patients and improve their lives.

Tessera Scientific Advisory Board Member David Schaffer co-invented the company's foundational technology as UC Berkeley Professor of Chemical and Biomolecular Engineering, Bioengineering, Molecular and Cell...

ReRx Therapeutics

Brief Description

ReRx is developing novel oral therapeutics to treat patients with severe metabolic diseases including obesity, metabolic syndrome, diabetes, and liver diseases. The company's therapeutics target metabolic pathways involved in regulating energy homeostasis and improve treatment outcomes compared to similar pharmacological agents.

Timeline 2023. Company founded; Joins Berkeley Skydeck Cohort 17 Inventors

Chi Zhu, Anders Michael Naar, Justin Yu-Sun Lee

AsparaGlue

Brief Description

AsparaGlue has developed a superglue-like medical adhesive for external wound closure and internal tissue adhesion. The proprietary technology is the world’s only biocompatible and biodegradable medical superglue.

Timeline 2023. Company founded; joins Berkeley Skydeck accelerator, cohort 16 Inventors

Philip Messersmith, Subhajit Pal, Ji Soo Shin, Kelsey Gray DeFrates

MZR Neurotech

Brief Description

MZR Neurotech has developed an in-ear electroencephalogram (EEG) sensor packed with biosensors that detect brain activity. The discreet, comfortable brain-machine interface is being developed for monitoring and diagnosing sleep disorders.

Timeline 2023. Company founded Inventors

Ryan Kaveh, Arya Reais-Parsi, Rikky Muller, Saavan Patel

Resvita Biosciences

Brief Description

Resvita Biosciences seeks to restore and maintain the vitality of the skin by properly considering the skin microbiome as part of the human body. A harmless skin probiotic will continuously deliver the therapy that a body would to maintain skin health.

Through synthetic biology and metabolic engineering, the company's goal is to develop a safe and versatile skin microbial platform that can address the causes of skin aging and disease. Resvita Biosciences has a unique patented approach, a rich product pipeline, clear regulatory advantages, and an experienced...

Monolets, Inc

Brief Description

MonoLets, Inc. is a systems company developing a wireless sensor network for the Internet of Things. The company builds the network with the lowest power System-on-Chip (SoC) hardware platform that can be operated from harvested energy requiring no external battery. The company's patented silicon and wireless mesh technology was developed over five years of research and development at UC Berkeley. Monolets' mission is to enable extremely reliable connectivity in challenging RF environments (metal & liquid obstruction), thereby providing access to real-time information...